T1	Participants 70 114	pulmonary arterial hypertension in children.
T2	Participants 191 229	pulmonary arterial hypertension (PAH).
T3	Participants 543 615	29 children treated with inhaled treprostinil for â‰¥6 weeks was performed
T4	Participants 1834 1861	pediatric patients with PAH
